Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT03967223
Brief Title: Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (IGNYTE-ESO)

First Submitted : May 10, 2019
First Submitted that Met QC Criteria : May 28, 2019
First Posted : May 30, 2019

Last Update Submitted that Met QC Criteria : February 1, 2022
Last Update Posted : February 16, 2022